Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Medicare Shakeup: Policy Changes Rattle Big Insurers

by Team Lumida
May 17, 2024
in Macro, News
Reading Time: 4 mins read
A A
0
emergency signage

Photo by Pixabay on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Biden administration’s policy changes reduce Medicare Advantage profitability.
  2. Insurers like CVS and Humana face rising costs and declining profits.
  3. Market and regulatory challenges could reshape the future of Medicare Advantage.

What Happened?

The Medicare Advantage landscape has dramatically shifted. Medicare Advantage, a program where the government pays insurers to manage senior care, has been a major profit driver for companies like UnitedHealth Group and Humana. However, the Biden administration’s recent policy changes have altered the payment structures, causing a significant dip in profitability.

CVS Health’s Aetna unit reported a $900 million surge in unexpected medical costs, leading to its largest one-day share drop in nearly 15 years. As a result, CVS shares have plunged 26% this year, equating to a market cap of just over $70 billion—the same amount it paid for Aetna in 2018. Humana and UnitedHealth have also seen their shares drop by over 20% and 16%, respectively.

Why It Matters?

These changes have rattled investors and corporate boards, signaling a shift from growth to profitability in the Medicare Advantage sector. With the government tightening its purse strings and implementing stricter policies, insurers must adapt quickly. CVS plans to exit some markets and cut back on benefits to improve margins.

Thomas Cowhey, CVS Chief Financial Officer, stated, “The goal for next year is margin over membership.” This shift could open opportunities for companies with better profit margins like UnitedHealth to gain market share. However, the regulatory environment remains a tougher challenge, with tighter payment rates and changes in coding patient risk.

What’s Next?

Insurers are now focusing on mitigating rising costs and adapting to new regulations. Expect strategic exits from less profitable markets and reductions in member benefits. Analysts predict Humana, despite expected lower earnings this year, will rebound to $26 per share by 2026. The industry’s lobbying efforts will intensify to influence public and policymaker opinions.

Wendell Potter, a former Cigna executive, highlighted, “Companies will be investing heavily through campaign donations and lobbying.” A potential Donald Trump win in the upcoming presidential elections could favor privatization and benefit Medicare Advantage. Regardless, the sector remains profitable but without the extraordinary gains seen in recent years.

Source: WSJ
Previous Post

Why Bitcoin’s Correlation with Nasdaq Is Skyrocketing

Next Post

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Recommended For You

Costco’s US Comparable Sales May Grow More Than 10% in November as Tech Outages Spark Emergency Stockpiling, Mizuho Says, Raising Its Target to $1,150

by Team Lumida
2 hours ago

Mizuho said tech outages are driving panic buying at Costco, estimating late-October US comps ex-gas rose 11% to 12%, and lifted its target to $1,150.

Read more

Textron Sells Its Industrial Segment to Kingswood Capital for $1.2 Billion and Authorizes a 35 Million-Share Buyback to Focus on Aviation, Bell and Defense

by Team Lumida
2 hours ago

Textron agreed to sell its industrial unit for $1.2 billion, expects about $1.1 billion in net proceeds, and approved a new 35 million-share buyback.

Read more

Apple Trades at 37 Times Forward Earnings, Its Highest Since 2007, After a 30% Gain Makes It the Market’s AI Haven and a $5.1 Trillion Company

by Team Lumida
2 hours ago

Apple’s 30% gain this year has pushed it to 37 times forward earnings and a record PEG ratio, as investors pay up for a stock seen as an...

Read more

Bitcoin Erases Its Bessent Rally Near $64,000 as Perpetual Futures Open Interest Falls to $41.6 Billion, the Lowest Since November 2024, and Citi Cuts Its Targets

by Team Lumida
2 hours ago

Bitcoin wiped out its late-summer rally as leverage and liquidity faded, ETF outflows hit $2.6 billion this month, and Citi trimmed its BTC and ETH targets.

Read more

MARA Prices $185 Million of 8.75% Debt to Help Fund Its $1.5 Billion Ohio Power Plant Deal, a Week After Selling $1.1 Billion of Bitcoin to Repay Loans

by Team Lumida
2 hours ago

MARA priced $185 million of 8.75% bonds tied to its Long Ridge power plant purchase, and its shares rose about 4.7% premarket.

Read more

Pending Home Sales Fall 4.7% to the Lowest in the Index’s 25-Year History, as Single-Family Permits Drop 8.7% to a May 2020 Low and Mortgage Applications Slip 2.3%

by Team Lumida
2 hours ago

Pending home sales hit a record low in October, single-family permits fell 8.7%, and mortgage applications dropped as rates rose to 7.35%.

Read more

TJX Raises Its Full-Year EPS Outlook to $5.17-$5.20 After Comparable Sales Rise 4% and Sales Hit $16 Billion, Sending Shares Up 6.6% Premarket

by Team Lumida
2 hours ago

TJX raised its full-year profit outlook after Q3 sales rose 6% to $16 billion and comparable sales beat at 4%, sending the stock up 6.6% premarket.

Read more

Lowe’s Raises Its Sales Outlook to About $92.5 Billion as Online Sales Jump 17.4% and Comparable Sales Rise 1.8%, Yet Shares Slip More Than 3% Premarket

by Team Lumida
2 hours ago

Lowe’s lifted its full-year sales outlook to about $92.5 billion on 17.4% online growth and pro strength, though shares fell more than 3% premarket.

Read more

Jensen Huang and Commerce Secretary Lutnick Agree to Appear Before the Senate Banking Committee, as House Democrats Probe Cantor Fitzgerald’s Nvidia Holdings

by Team Lumida
2 hours ago

Tim Scott said Huang and Lutnick agreed to appear before Christmas, as House Democrats sought records on Cantor Fitzgerald’s Nvidia stake.

Read more

Dow Drops 426 Points as Nvidia’s Post-Earnings Bounce Fizzles, With CoreWeave Down 6%, Nebius 4% and Iren 3% as Neoclouds Reverse Early Gains

by Team Lumida
2 hours ago

The Dow fell 426 points as Nvidia gave up its post-earnings gains, while CoreWeave, Nebius and Iren reversed early premarket jumps.

Read more
Next Post
woman with face mask holding an alcohol bottle

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

flag hanging on pole

JPMorgan’s $40 Billion Indian Bond Bet:

June 20, 2024
Crypto Startups Are Still Being Funded at Last Year’s Pace. Almost No New Crypto Funds Are Being Raised

One Fund Took $665 Million While the Rest of the Bitcoin ETFs Lost $139 Million

October 20, 2026
a close up of a coin on a table

Can Cryptocurrency Save the U.S. Economy? Trump Thinks So!

August 4, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018